SCHEMBL18052018

SCHEMBL18052018

CCc1cnc(-c2c[nH]c3ncc(Cl)cc23)nc1N[C@@H]1CCN(C(C)=O)C1

nearest known ligand 0.60

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 1/20 0.44
▸ JAK3 P52333 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10008085 0.89 — —
SCHEMBL10008081 0.89 — —
SCHEMBL10006733 0.84 — —
SCHEMBL10006731 0.84 — —
SCHEMBL18720565 0.82 — —
SCHEMBL18052010 0.81 CDC7 (0.49) JAK3
SCHEMBL28333089 0.81 GSK3A (0.54) —
SCHEMBL28333172 0.81 GSK3A (0.54) —
SCHEMBL28333085 0.81 GSK3A (0.54) —
SCHEMBL10007054 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3141252-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION Vertex Pharmaceuticals Inc. (US) 2017-03-15 — — EP disclosed
EP-2442809-B1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION VERTEX PHARMA (US) 2016-08-31 — — EP disclosed
Send feedback